Colot, Ernesto D.

HRN: 22-50-85  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/30/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/30/2023
02/05/2023
IV
2.25 Grams
Q 8 Hours
Sepsis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: No  Wrong Dose  Optimize Dose

Overall appropriateness: No  Optimize Dose

Intervention



Type of Intervention done:

                    

           


Acceptance: